LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.50 | 21.74 | 6887 | 5425 | 1.2693 | 1.0608 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 55.48 | 21.74 | 125 | 5768 | 0.0217 | 0.2426 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 55.48 | 21.74 | 7867 | 5768 | 1.3637 | 1.0786 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 55.48 | 21.74 | 5615 | 5768 | 0.9733 | 0.9933 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 55.48 | 21.74 | 7366 | 5768 | 1.2769 | 1.0616 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 57.45 | 21.74 | 124 | 6023 | 0.0206 | 0.2393 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 57.45 | 21.74 | 8562 | 6023 | 1.4214 | 1.0886 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 57.45 | 21.74 | 5259 | 6023 | 0.8731 | 0.9668 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 57.45 | 21.74 | 7912 | 6023 | 1.3135 | 1.0684 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.42 | 21.74 | 104 | 6125 | 0.0170 | 0.2121 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.42 | 21.74 | 9112 | 6125 | 1.4876 | 1.1000 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.42 | 21.74 | 5137 | 6125 | 0.8386 | 0.9572 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.42 | 21.74 | 8470 | 6125 | 1.3828 | 1.0813 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 62.39 | 21.74 | 124 | 6112 | 0.0203 | 0.2387 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 62.39 | 21.74 | 9548 | 6112 | 1.5620 | 1.1127 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 62.39 | 21.74 | 4527 | 6112 | 0.7406 | 0.9275 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 62.39 | 21.74 | 8982 | 6112 | 1.4694 | 1.0969 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.36 | 21.74 | 106 | 6191 | 0.0171 | 0.2145 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.36 | 21.74 | 10040 | 6191 | 1.6217 | 1.1222 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.36 | 21.74 | 3779 | 6191 | 0.6104 | 0.8825 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.36 | 21.74 | 9441 | 6191 | 1.5250 | 1.1062 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.33 | 21.74 | 90 | 6235 | 0.0144 | 0.1901 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.33 | 21.74 | 10460 | 6235 | 1.6775 | 1.1308 | MN20160310_N01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.33 | 21.74 | 2694 | 6235 | 0.4320 | 0.8046 | MN20160310_N01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.33 | 21.74 | 9816 | 6235 | 1.5742 | 1.1143 | MN20160310_N01 | L07 |